Founders Financial Securities LLC Acquires 337 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Founders Financial Securities LLC lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,570 shares of the exchange traded fund’s stock after acquiring an additional 337 shares during the quarter. Founders Financial Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $529,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Envestnet Asset Management Inc. raised its stake in SPDR S&P Biotech ETF by 5.8% during the third quarter. Envestnet Asset Management Inc. now owns 126,001 shares of the exchange traded fund’s stock valued at $9,201,000 after buying an additional 6,884 shares during the last quarter. Synovus Financial Corp boosted its stake in SPDR S&P Biotech ETF by 9.3% in the 3rd quarter. Synovus Financial Corp now owns 5,018 shares of the exchange traded fund’s stock worth $366,000 after purchasing an additional 429 shares in the last quarter. Alerus Financial NA grew its position in SPDR S&P Biotech ETF by 0.6% during the 3rd quarter. Alerus Financial NA now owns 54,655 shares of the exchange traded fund’s stock valued at $3,991,000 after purchasing an additional 349 shares during the last quarter. Sectoral Asset Management Inc. increased its stake in SPDR S&P Biotech ETF by 36.8% during the 3rd quarter. Sectoral Asset Management Inc. now owns 24,675 shares of the exchange traded fund’s stock valued at $1,802,000 after purchasing an additional 6,643 shares in the last quarter. Finally, Scotia Capital Inc. increased its stake in SPDR S&P Biotech ETF by 4.9% during the 3rd quarter. Scotia Capital Inc. now owns 41,137 shares of the exchange traded fund’s stock valued at $3,004,000 after purchasing an additional 1,933 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.2 %

Shares of NYSEARCA XBI traded down $0.15 during midday trading on Friday, hitting $92.71. The stock had a trading volume of 7,872,582 shares, compared to its average volume of 10,728,328. The business’s 50 day moving average is $89.95 and its 200-day moving average is $90.80. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The company has a market cap of $7.07 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.